International Association for the Study of Lung Cancer
The only global society devoted to lung and thoracic cancers, whose World Conference on Lung Cancer and TNM staging project define the field.
Founded in 1974, IASLC has more than 8,000 members in over 100 countries and publishes the Journal of Thoracic Oncology and JTO Clinical and Research Reports. Its Staging and Prognostic Factors Committee runs the international database behind the TNM classification for lung cancer, mesothelioma and thymic tumours (ninth edition 2024), and its World Conference on Lung Cancer is the annual venue for thoracic oncology trials, from EGFR and ALK inhibitors to neoadjuvant immunotherapy and ADCs. IASLC issues pathology and biomarker atlases (PD-L1, ALK, MET), the Lung Cancer Screening guidelines and the Grading System for lung adenocarcinoma, and its Tobacco Control Committee and Early Detection Committee drive global screening advocacy.
- World Conference on Lung Cancer
- TNM staging project for thoracic cancers
- Journal of Thoracic Oncology
- Biomarker and pathology atlases
- Screening and tobacco control advocacy
Co-led ADAURA and IPASS, the trials that made EGFR-targeted pills standard before and after surgery.
Co-discovered EGFR mutations in lung cancer and has led the drug development that followed, from osimertinib to KRAS G12C inhibitors.
Principal investigator of CROWN, where lorlatinib produced the longest disease control ever recorded for a targeted lung cancer pill.
Fiona Blackhall is a thoracic oncologist leading small-cell lung cancer trials and biomarker research at The Christie.
Pages like this
not linked directly; found by shared links- InstitutionIntergroupe Francophone de Cancérologie Thoracique
Shares Oncogene addiction, Mesothelioma, Small-cell lung cancer, Comprehensive genomic profiling.
- InstitutionGuangdong Provincial People's Hospital
Shares Yi-Long Wu, Oncogene addiction, Comprehensive genomic profiling, Small-molecule kinase inhibitors.
- InstitutionShanghai Pulmonary Hospital
Shares CT (computed tomography), Small-cell lung cancer, Small-molecule kinase inhibitors, Immune checkpoint inhibitors.
- InstitutionWest Japan Oncology Group
Shares Oncogene addiction, Small-cell lung cancer, Small-molecule kinase inhibitors, Immune checkpoint inhibitors.
- InstitutionCancer Research UK Manchester Institute
Shares Fiona Blackhall, Small-cell lung cancer, Comprehensive genomic profiling, Non-small-cell lung cancer.
- Key paperADAURA: three years of osimertinib after surgery for EGFR-mutated lung cancer
Shares Yi-Long Wu, Oncogene addiction, Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- InstitutionChinese Society of Clinical Oncology
Shares Yi-Long Wu, European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Immune checkpoint inhibitors.
- TechnologyLow-dose CT lung screening
Shares LUNGevity Foundation (and GO2 for Lung Cancer), CT (computed tomography), AI in radiology, Small-cell lung cancer.